Four of 126 (3.2%) patients with confirmed TBE tested false-negative for IgM in serum, due to prior rituximab treatment (n = 2) or vaccine breakthrough infection (n = 2). The gene discussed is CD40LG; the disease is tick-borne encephalitis.